These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 35976612)

  • 1. Synthesis of 2-Acetamido-1,3,4-Tri-O-Acetyl-2-Deoxy-D-Mannopyranose -6-Phosphate Prodrugs as Potential Therapeutic Agents.
    Pertusati F; Morewood J
    Curr Protoc; 2022 Aug; 2(8):e500. PubMed ID: 35976612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting GNE Myopathy: A Dual Prodrug Approach for the Delivery of
    Morozzi C; Sedláková J; Serpi M; Avigliano M; Carbajo R; Sandoval L; Valles-Ayoub Y; Crutcher P; Thomas S; Pertusati F
    J Med Chem; 2019 Sep; 62(17):8178-8193. PubMed ID: 31386361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety, pharmacokinetics and sialic acid production after oral administration of N-acetylmannosamine (ManNAc) to subjects with GNE myopathy.
    Xu X; Wang AQ; Latham LL; Celeste F; Ciccone C; Malicdan MC; Goldspiel B; Terse P; Cradock J; Yang N; Yorke S; McKew JC; Gahl WA; Huizing M; Carrillo N
    Mol Genet Metab; 2017 Sep; 122(1-2):126-134. PubMed ID: 28641925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Versatile intermediates in the selective modification of the amino function of 2-amino-2-deoxy-D-mannopyranose and the 3-position of 2-acetamido-2-deoxy-D-mannose: potential membrane modifiers in neoplastic control.
    Angelino NJ; Bernacki RJ; Sharma M; Dodson-Simmons O; Korytnyk W
    Carbohydr Res; 1995 Oct; 276(1):99-115. PubMed ID: 8536261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population Pharmacokinetic Model of N-acetylmannosamine (ManNAc) and N-acetylneuraminic acid (Neu5Ac) in Subjects with GNE Myopathy.
    Van Wart S; Mager DE; Bednasz CJ; Huizing M; Carrillo N
    Drugs R D; 2021 Jun; 21(2):189-202. PubMed ID: 33893973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Animal model of distal myopathy with rimmed vacuoles/hereditary inclusion body myopathy and preclinical trial with sugar compounds].
    Noguchi S; Malicdan MC; Nishino I
    Brain Nerve; 2010 Jun; 62(6):601-7. PubMed ID: 20548120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral monosaccharide therapies to reverse renal and muscle hyposialylation in a mouse model of GNE myopathy.
    Niethamer TK; Yardeni T; Leoyklang P; Ciccone C; Astiz-Martinez A; Jacobs K; Dorward HM; Zerfas PM; Gahl WA; Huizing M
    Mol Genet Metab; 2012 Dec; 107(4):748-55. PubMed ID: 23122659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of the methyl thioglycosides of deoxy-N-acetyl-neuraminic acids for use as glycosyl donors.
    Hasegawa A; Adachi K; Yoshida M; Kiso M
    Carbohydr Res; 1992 Jun; 230(2):257-72. PubMed ID: 1394300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-acetyl-D-mannosamine analogues as potential inhibitors of sialic acid biosynthesis.
    Hadfield AF; Mella SL; Sartorelli AC
    J Pharm Sci; 1983 Jul; 72(7):748-51. PubMed ID: 6577183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and reactions of O-acetylated benzyl alpha-glycosides of 6-O-(2-acetamido-2-deoxy-beta-D-glucopyranosyl)-N-acetylmuramoyl-L- alanyl-D-isoglutamine esters: the base-catalysed isoglutamine in equilibrium glutamine rearrangement in peptidoglycan-related structures.
    Keglević D; Derome AE
    Carbohydr Res; 1989 Feb; 186(1):63-75. PubMed ID: 2720705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine isoforms of UDP-GlcNAc 2-epimerase/ManNAc kinase: Secondary structures, expression profiles, and response to ManNAc therapy.
    Yardeni T; Jacobs K; Niethamer TK; Ciccone C; Anikster Y; Kurochkina N; Gahl WA; Huizing M
    Glycoconj J; 2013 Aug; 30(6):609-18. PubMed ID: 23266873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of N-acetylmannosamine (ManNAc) in patients with GNE myopathy: an open-label phase 2 study.
    Carrillo N; Malicdan MC; Leoyklang P; Shrader JA; Joe G; Slota C; Perreault J; Heiss JD; Class B; Liu CY; Bradley K; Jodarski C; Ciccone C; Driscoll C; Parks R; Van Wart S; Bayman L; Coffey CS; Quintana M; Berry SM; Huizing M; Gahl WA
    Genet Med; 2021 Nov; 23(11):2067-2075. PubMed ID: 34257421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-specific accumulation of glycosphingolipids in GNE myopathy.
    Patzel KA; Yardeni T; Le Poëc-Celic E; Leoyklang P; Dorward H; Alonzi DS; Kukushkin NV; Xu B; Zhang Y; Sollogoub M; Blériot Y; Gahl WA; Huizing M; Butters TD
    J Inherit Metab Dis; 2014 Mar; 37(2):297-308. PubMed ID: 24136589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological evaluation of a series of 2-acetamido-2-deoxy-D-glucose analogs towards cellular glycosaminoglycan and protein synthesis in vitro.
    Berkin A; Szarek WA; Kisilevsky R
    Glycoconj J; 2005 Nov; 22(7-9):443-51. PubMed ID: 16311889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lec3 Chinese hamster ovary mutants lack UDP-N-acetylglucosamine 2-epimerase activity because of mutations in the epimerase domain of the Gne gene.
    Hong Y; Stanley P
    J Biol Chem; 2003 Dec; 278(52):53045-54. PubMed ID: 14561743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of C-3 nitrogen-containing derivatives of N-acetyl-alpha,beta-D-mannosamine as substrates for N-acetylneuraminic acid aldolase.
    Kok GB; Campbell M; Mackey BL; von Itzstein M
    Carbohydr Res; 2001 May; 332(2):133-9. PubMed ID: 11434370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transport of N-acetyl-D-mannosamine and N-acetyl-D-glucosamine in Escherichia coli K1: effect on capsular polysialic acid production.
    Revilla-Nuin B; Reglero A; Martínez-Blanco H; Bravo IG; Ferrero MA; Rodríguez-Aparicio LB
    FEBS Lett; 2002 Jan; 511(1-3):97-101. PubMed ID: 11821056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visualizing Muscle Sialic Acid Expression in the GNED207VTgGne-/- Cmah-/- Model of GNE Myopathy: A Comparison of Dietary and Gene Therapy Approaches.
    Crowe KE; Zygmunt DA; Heller K; Rodino-Klapac L; Noguchi S; Nishino I; Martin PT
    J Neuromuscul Dis; 2022; 9(1):53-71. PubMed ID: 34511508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The synthesis of a trisaccharide and a tetrasaccharide lipid intermediate. P1-dolichyl P2-[O-beta-D-mannopyranosyl-(1----4)-O-(2-acetamido-2-deoxy- beta-D-glucopyranosyl)-(1----4)-2-acetamido-2-deoxy-alpha-D- glucopyranosyl] diphosphate and P1-dolichyl P2-[O-alpha-D-mannopyranosyl-(1----3)-O-beta-D- mannopyranosyl-(1----4)-O-(2-acetamido-2-deoxy-beta-D-glucopyranosyl)- (1----4)-2-acetamido-2-deoxy-alpha-D-glucopyranosyl] diphosphate.
    Warren CD; Milat ML; Augé C; Jeanloz RW
    Carbohydr Res; 1984 Mar; 126(1):61-80. PubMed ID: 6713432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of a fucosylated and a non-fucosylated core structure of xylose-containing carbohydrate chains from N-glycoproteins.
    van der Ven JG; Kerékgyártó J; Kamerling JP; Lipták A; Vliegenthart JF
    Carbohydr Res; 1994 Nov; 264(1):45-62. PubMed ID: 8001019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.